Alvotech (NASDAQ:ALVOW – Get Free Report)’s share price fell 15.8% during trading on Thursday . The company traded as low as $0.30 and last traded at $0.32. Approximately 1,917 shares changed hands during trading, a decline of 59% from the average session volume of 4,639 shares. The stock had previously closed at $0.3799.
Alvotech Stock Down 6.3%
The stock has a 50 day simple moving average of $0.21 and a 200-day simple moving average of $0.25.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Further Reading
- Five stocks we like better than Alvotech
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
- Merchants Bancorp’s Rally Is Testing How Much Risk Investors Will Overlook
- Lululemon’s Earnings Beat Hid a Bigger Problem for Its Turnaround Story
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
